Sulphonamides: Updates on use in veterinary medicine

Veterinary Dermatology

Volumn 10, Issue 3, 1999, Pages 205-215

  Campbell, Karen L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cat; Dog; Potentiated sulphonamides; Skin; Sulphonamides

Indexed keywords

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; FELIS CATUS;

EID: 0033413176     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3164.1999.00181.x     Document Type: Article

References (40)

1. Mandell, G.L., Petri, W.A. Jr. Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract. In: Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Gilman, A.G., eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1996: 1057-72.
2. Allen, D.G., Pringle, J.K., Smith, D.A., Conlon, P.D., Burgmann, P.M. Handbook of Veterinary Drugs. Philadelphia; J. B. Lippincott, Company, 1993: 33-41, 260-4, 338-40, 472-8.
3. Craig, G.R., White, G. Studies in dogs and cats dosed with trimethoprim and sulphadiazine. Veterinary Record 1976; 98: 82-6.
4. Greene, C.E. Infectious Diseases of the Dog and Cat, 2nd edn. Philadelphia: W.B. Saunders Co., 1998: 197-8, 308-12, 322-4, 884-5, 904-7, 914-5.
5. Plumb, D.C. Pocket Edition Veterinary Drug Handbook, 2nd edn. Ames: Iowa State Press, 1995: 631-42.
6. Wilcke, J.R. Therapeutic application of sulfadiazine/ trimethoprim in dogs and cats: a review. Companion Animal Practice 1988; 2: 3-8.
7. Scott, D.W., Miller, W.H. Jr, Griffin, C.E. Muller and Kirk's Small Animal Dermatology, 5th edn. Philadelphia: W.B. Saunders Co., 1995: 218-21.
8. Bourdeau, P. Treatment of canine pyodermas with an oral long-acting association: baquiloprim + sulphadimethoxine (Zaquilan). In: Kwochka, K. W., Willemse, T., von Tscharner, C. Advances in Veterinary Dermatology, Vol. 3. Oxford: Butterworth Heinemann, 1998: 541-2.
9. DeBoer, D.J. Strategies for management of recurrent pyoderma in dogs. Veterinary Clinics of North America: Small Animal Practice 1990; 20: 1509-24.
10. Ihrke, P.J. Bacterial Skin Disease in the Dog: a Guide to Canine Pyoderma. Shawnee Mission, Kansas: Bayer Corporation Agricultural Division, 1996: 63-74.
11. Ihrke, P.J. Therapeutic strategies involving antimicrobial treatment of the skin in small animals. Journal of the American Veterinary Medical Association 1984; 185: 1165-8.
12. Medleau, L., Long, R.E., Brown, L.J., Miller, W.H. Jr. Frequency and antimicrobial susceptibility of staphylococcal species isolated from canine pyoderma. American Journal of Veterinary Research 1986; 47: 229-31.
13. Messinger, L.M., Beale, K.M. A blinded comparison of the efficacy of daily and twice daily trimethoprimsulfadiazine and daily sulfadimethoxine-ormetoprim therapy in the treatment of canine pyoderma. Veterinary Dermatology 1993; 4: 13-8.
14. Noble, W.C., Kent, L.E. Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog. Veterinary Dermatology 1992; 3: 71-4.
15. Papich, M.G. Antibacterial choices for skin infections. Bayer Selected Proceedings, North American Veterinary Conference 1998: 75-8.
16. Scott, D.W., Miller, W.H. Jr, Wellington, J.R. The combination of ormetoprim and sulfadimethoxine in the treatment of pyoderma due to Staphylococcus intermedius infection in dogs. Canine Practice 1993; 18: 29-33.
17. ® once-a-day canine antibacterial has important advantages. SmithKline Beecham Animal Health Technical Bulletin 1994; July 1-6.
18. Tribrissen product monograph. In: Arrioja-Dechert, A. Compendium of Veterinary Products. Port Huron, Michigan: Adrian J. Bayley, 1999: 2148-50.
19. White, S.D. Systemic treatment of bacterial skin infections of dogs and cats. Veterinary Dermatology 1996; 7: 133-43.
20. Sigel, C.W., Ling, G.V., Bushby, S.R.M., Woolley, J.L. Jr, DeAngelis, D., Eure, S. Pharmacokinetics of trimethoprim and sulfadiazine in the dog: urine concentrations after oral administration. American Journal of Veterinary Research 1981; 42: 996-1001.
21. Roepke, R.R., Maren, T.H., Mayer, E. Experimental investigations of sulfamethoxypyridazine. Annals New York Academy of Sciences 1957; 69: 456-72.
22. Primor product monograph. In: Arrioja-Dechert, A. Compendium of Veterinary Products. Port Huron, Michigan: Adrian J. Bayley, 1999: 1876-7.
23. Klotz, U., Maier, K., Fischer, C., Heinkel, K. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. New England Journal of Medicine 1980; 303: 1499-502.
24. Albon product monographs. In: Arrioja-Dechert, A., eds. Compendium of Veterinary Products. Port Huron, Michigan: Adrian J. Bayley, 1999: 1036-40.
25. Houvinen, P. Trimethoprim resistance. Antimicrobial Agents and Chemotherapeutics 1987; 31: 1451-6.
26. Cox, H.C., Hoskins, J.D., Roy, A.F. Antimicrobial susceptibility of coagulase positive staphylococci isolated from Louisiana dogs. American Journal of Veterinary Research 1984; 45: 2039-42.
27. Pohlenz-Zertuche, H.O., Brown, M.P., Gronwall, R., Kunkle, G.A., Merrit, K. Serum and skin concentrations after multiple-dose oral administration of trimethoprim-sulfadiazine in dogs. American Journal of Veterinary Research 1992; 53: 1273-6.
28. Kinzie, B.J., Taylor, J.W. Trimethoprim and folinic acid. Annals of Internal Medicine 1984; 101: 565-9.
29. Gurwith, J.J., Brunton, J.L., Lank, B.A., Harding, G.K.M., Ronald, A.R. A prospective controlled investigation of prophylactic trimethoprim-sulfamethoxazole in hospitalized granulocytopenic patients. American Journal of Medicine 1979; 66: 248-56.
30. Kauffman, C.A., Liepman, M.K., Bergman, A.G., Mioduszewski, J. Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. American Journal of Medicine 1983; 74: 599-607.
31. Giger, U., Werner, L.L., Millichamp, N.J., Gorman, N.T. Sulfadiazine-induced allergy in six Doberman pinschers. Journal of the American Veterinary Medical Association 1985; 186: 479-84.
32. Kunkle, G.A., Sundlof, S., Keisling, K. Adverse side effects of oral antibacterial therapy in dogs and cats: an epidemiologic study of pet owners' observations. Journal of the American Animal Hospital Association 1995; 31: 46-55.
33. Lording, P.M., Bellamy, J.E.C. Trimethoprim and sulfadiazine: adverse effects of long-term administration in dogs. Journal of the American Animal Hospital Association 1978; 14: 410-7.
34. Fox, L.E., Ford, S., Alleman, A.R., Homer, B.L., Harvey, J.W. Aplastic anemia associated with prolonged high-dose trimethoprim-sulfadiazine administration in two dogs. Veterinary Clinical Pathology 1993; 22: 89-92.
35. Berger, S.L., Scagliotti, R.H., Lund, E.M. A quantitative study of the effects of Tribrissen on canine tear production. Journal of the American Animal Hospital Association 1995; 31: 236-41.
36. Hall, I.A., Campbell, K.L., Chambers, M.D., Davis, C.A. Effect of trimethoprim/sulfamethoxazole on thyroid function in dogs with pyoderma. Journal of the American Veterinary Medical Association 1993: 202: 1959-62.
37. Campbell, K.L., Nachreiner, R., Schaeffer, D.J., Davis, C.A. Effect of trimethoprim/sulfamethoxazole on endogenous thyroid stimulating hormone concentrations in dogs. In: Kwochka, K.W., Willemse, T., von Tscharner, C. Advances in Veterinary Dermatology, Vol. 3. Oxford: Butterworth Heinemann, 1998: 237-42.
38. Twedt, D.C., Diehl, K.J., Lappin, J.R., Getzy, D.M. Association of hepatic necrosis with trimethoprim sulfonamide administration in 4 dogs. Journal of Veterinary Internal Medicine 1997; 11: 20-3.
39. Trepanier, L. Delayed hypersensitivity reactions to sulphonamides: syndromes, pathogenesis and management. Veterinary Dermatology, 1999; 10: 241-248.
40. Hall, J.A., Campbell, K.L. The effect of potentiated sulfonamides on canine thyroid function. In: Bonagura, J.D., Kirk, R.W., eds. Kirk's Current Veterinary Therapy XII Small Animal Practice. Philadelphia: W.B. Saunders, Co., 1995: 595-7.